🕵️ Vivos Therapeutics, Inc. ($VVOS)
SEC insider & ownership activity, last 12 months · CIK 1716166 · every row links its SEC filing
Insider buy value was withheld pending verification over the last 12 months. One red-flag 8-K in the window: Delisting notice (3.01), Jun 8, 2026.
Insider flow
1 buyer, value withheld pending verification (8 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Michael C. Skaff | 8 | value withheld pending verification | 0 | – | Jun 30, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| SP Manager LLC | 19.9% | 13D | Jun 30, 2026 | filing ↗ | |
| Michael C. Skaff | 19.9% | 13D | Jun 30, 2026 | filing ↗ | |
| V-CO Investors 3 LLC | 9.7% | 13D | Jun 30, 2026 | filing ↗ | |
| Dawei Luo | 8.5% | 13G | Jul 14, 2025 | filing ↗ | |
| V-CO Investors 2 LLC | 5.9% | 13D | Jun 30, 2026 | filing ↗ | |
| Streeterville Capital LLC | exited | 13G | Sep 3, 2026 | filing ↗ | |
| Streeterville Management, LLC | exited | 13G | Sep 3, 2026 | filing ↗ | |
| John M. Fife | exited | 13G | Sep 3, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Sep 2, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Sep 2, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 2, 2026 | filing ↗ |
| Material agreement (1.01) | Aug 31, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Aug 31, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 31, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 20, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 5, 2026 | filing ↗ |
| Material agreement (1.01) | Jul 31, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jul 31, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 31, 2026 | filing ↗ |
| Material agreement (1.01) | Jul 7, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jul 7, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Jul 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 7, 2026 | filing ↗ |
| Material agreement (1.01) | Jun 25, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 25, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 25, 2026 | filing ↗ |
| Other events (8.01) | Jun 16, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 16, 2026 | filing ↗ |
| Material agreement (1.01) | Jun 15, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 15, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 15, 2026 | filing ↗ |
| Material agreement (1.01) | Jun 8, 2026 | filing ↗ |
| New financial obligation (2.03) | Jun 8, 2026 | filing ↗ |
| Delisting notice (3.01) | Jun 8, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jun 8, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 8, 2026 | filing ↗ |